Skip to main content
Clinical Trials/ITMCTR2200005576
ITMCTR2200005576
Not yet recruiting
未知

Real world clinical research and development application of Roogan Tongluo Granule (renamed Sangdan Tongluo granule) in the treatment of ischemic stroke

Affiliated Hospital of Hunan Academy of Chinese Medicine0 sitesTBD
ConditionsIschemic stroke

Overview

Phase
未知
Intervention
Not specified
Conditions
Ischemic stroke
Sponsor
Affiliated Hospital of Hunan Academy of Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational study
Sex
All

Investigators

Sponsor
Affiliated Hospital of Hunan Academy of Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • ? Western diagnosis conforms to the diagnostic criteria of ischemic stroke;? TCM diagnosis belongs to apoplexy;? The duration of the disease is between 2 weeks and 6 months;? Good compliance, aged between 18 and 75 years old;(5\) with limb dysfunction, and not accompanied by other diseases affecting neurological function and life ability evaluation;? Patients or their family members agree and sign informed consent.

Exclusion Criteria

  • ? The course of treatment is less than 1 month;? The medical records are not complete, and the return visit cannot be obtained.

Outcomes

Primary Outcomes

Not specified

Similar Trials